Jove
Visualize
联系我们

相关概念视频

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

24
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
24
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策
  1. 首页
  2. 冠状动脉旁路移植手术后的抗血栓治疗:esc心血管外科工作组,esc心血管药物治疗工作组和欧洲心胸外科协会 (eacts) 的临床共识声明
  1. 首页
  2. 冠状动脉旁路移植手术后的抗血栓治疗:esc心血管外科工作组,esc心血管药物治疗工作组和欧洲心胸外科协会 (eacts) 的临床共识声明

相关实验视频

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

6.5K

冠状动脉旁路移植手术后的抗血栓治疗:ESC心血管外科工作组,ESC心血管药物治疗工作组和欧洲心胸外科协会 (EACTS) 的临床共识声明

Sigrid Sandner1,2, Mario Gaudino2, Stefan Agewall3,4

  • 1Department of Cardiac and Thoracic Aortic Surgery, Medical University of Vienna, Spitalgasse 23, Vienna 1090, Austria.

European heart journal
|August 30, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

在冠状动脉旁路移植后选择抗血栓治疗需要平衡凝块预防和出血风险. 针对个体患者的治疗是最佳结果的关键.

关键词:
抗凝固药物治疗抗血小板治疗发生出血冠状动脉旁路移植移植失败

更多相关视频

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

相关实验视频

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

6.5K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

科学领域:

  • 心脏病学
  • 血管外科手术
  • 药理学

背景情况:

  • 抗血栓治疗是冠状动脉旁路移植 (CABG) 术后预防缺血事件和移植封闭的重要手段.
  • 阿司匹林是常见的,但高风险患者可能受益于双重抗血小板治疗或联合抗血小板和抗凝药,增加出血风险.

研究的目的:

  • 审查CABG后选择抗血栓治疗的科学证据.
  • 为最佳临床实践提供共识陈述.
  • 确定未来研究的领域.

主要方法:

  • 对CABG后抗血栓治疗的科学证据的审查.
  • 影响治疗选择的因素分析 (缺血风险与出血风险).
  • 综合共识声明和发现研究缺口.

主要成果:

  • 在CABG后,个性化的抗血栓治疗选择至关重要.
  • 预防缺血事件与出血风险之间的平衡是关键.
  • 目前的证据支持量身定制的方法,持续的研究需要.

结论:

  • 应根据患者特定的缺血和出血风险进行个性化治疗.
  • 建议定期重新评估治疗方法.
  • 需要进一步研究以优化不同患者群体的抗血栓治疗策略.